• Sumatriptan Succinate in Inflammation Research

  2026-09-16

  Learn how to deploy Sumatriptan as a 5-HT1 receptor agonist in serotonergic, neuroinflammatory, and metabolism workflows. This practical guide connects receptor-level assays with cytokine, CGRP, NF-κB, and ischemia/reperfusion readouts while emphasizing salt-form verification, dose design, and reproducibility.

• Ziprasidone Augmentation in Anxious Depression

  2026-09-15

  This post-hoc moderator analysis examined whether baseline anxious depression altered the effects of ziprasidone added to escitalopram in an 8-week randomized trial. Depression outcomes were similar in patients with and without anxious depression, while the apparent anxiety benefit in highly anxious participants was not clinically significant, limiting subgroup-based conclusions.

• RRP Restores Lipid Metabolism in Hepatic IRI

  2026-09-15

  A 2024 Journal of Ethnopharmacology study identifies lipid metabolic restoration as a central mechanism by which Radix Rehmanniae Praeparata extracts reduce hepatic ischemia-reperfusion injury. Its evidence connects AMPK activation with suppression of SCAP-SREBP2 cholesterol synthesis and enhancement of LXRα-dependent cholesterol efflux, providing a useful framework for lipid metabolism research.

• EZ Cap Cy5 Firefly Luciferase mRNA Workflow

  2026-09-14

  This dual-reporter transcript separates mRNA uptake from functional protein expression, making it useful for carrier screening, translation efficiency assays, and intracellular trafficking studies. Cy5 fluorescence provides an early delivery readout, while Firefly Luciferase supports sensitive endpoint or longitudinal bioluminescence measurements.

• iPSC Cardiomyocytes for Chemical Risk Characterization

  2026-09-14

  Tsai and colleagues show that combining functional phenotypes with transcriptomic responses in human iPSC-derived cardiomyocytes can improve chemical hazard prioritization and mechanistic interpretation. Across 464 chemicals, the integrated workflow connected concentration-response activity with points of departure and exposure-based risk characterization without relying on electrophysiology alone.

• Tetrandrine: An Evidence-to-Assay Guide

  2026-09-13

  Tetrandrine is a calcium-channel-modulating alkaloid best used as a carefully controlled mechanistic perturbation tool. This evidence-to-assay guide connects product handling, ion-channel experiments, and the limits of computational antiviral evidence.

• Lamotrigine Research Workflows for Ion Channels

  2026-09-12

  Build reproducible Lamotrigine assays for neuronal sodium-channel, cardiac electrophysiology, serotonin, and CYP19 workflows. This guide emphasizes solvent control, concentration design, orthogonal readouts, and troubleshooting for translational epilepsy and safety studies.

• Copper-Catalyzed Thioazafluoranthene Synthesis

  2026-09-11

  Chen and co-workers reported an air-compatible copper-catalyzed radical cascade that converts N-tosyl-8-ethynyl-1-naphthylamines into sulfur- and nitrogen-doped fluoranthene frameworks. The method combines broad synthetic utility with a notable fluorescence response, including a 143 nm Stokes shift for amino-linked products in dilute tetrahydrofuran.

• PGE2-Driven Schwann Cell Dedifferentiation in PDAC

  2026-09-11

  Wang and colleagues identify a paracrine PTGES–PGE2–Schwann cell axis that links pancreatic ductal adenocarcinoma to Schwann cell dedifferentiation and perineural invasion. By combining clinical transcriptomic analyses with coculture and three-dimensional models, the study implicates LIF and ADAMTS-1 as downstream factors that support neural remodeling and tumor invasion.

• Angiotensin Peptides Enhance SARS-CoV-2 Spike Binding

  2026-09-10

  A 2025 study found that naturally occurring angiotensin peptides can increase SARS-CoV-2 spike protein binding to AXL, with selected shorter and N-terminally truncated peptides showing stronger activity than longer parent sequences. The work identifies peptide length and residue chemistry as variables for receptor-binding studies, while also highlighting that the findings remain at the biochemical assay stage rather than demonstrating altered infection or clinical disease.

• Schizophrenia Risk Pathways in Developing Neurons

  2026-09-10

  Liu et al. show that schizophrenia-associated GWAS loci converge on different biological pathways in developing cortical interneurons and glutamatergic neurons. Their cell-type-resolved iPSC model links interneuron risk genes to PKC hyperactivity and arborization defects, while glutamatergic-neuron risk genes converge on ion transport and calcium-current abnormalities.

• TSPAN18–STIM1 Signaling in Prostate Cancer Bone Metastasis

  2026-09-09

  Zhou et al. identify TSPAN18 as a stabilizer of STIM1 that limits TRIM32-mediated ubiquitination and amplifies store-operated calcium entry in prostate cancer. The study connects this protein-quality-control mechanism to migration, invasion, bone metastasis, and adverse clinical features, providing a mechanistic framework for prostate cancer research.

• Escitalopram Assay Design: From 5-HTT to Translation

  2026-09-09

  Escitalopram research is strongest when transporter potency, assay context, and clinical moderators are interpreted together. This guide connects Lexapro pharmacology with practical 5-HT reuptake inhibition workflows and the limitations of augmentation evidence.

• Thiothixene: Neuroimmune Assay Workflows

  2026-09-08

  Thiothixene supports a practical bridge between dopamine receptor pharmacology and in vitro macrophage efferocytosis enhancement. This guide translates its Stra6l–vitamin A–arginase 1 biology into reproducible assay steps while keeping schizophrenia treatment and FGFR1-related findings appropriately distinct.

• Dasatinib: From Kinase Signals to Tumor State

  2026-09-08

  Dasatinib (BMS-354825) is more than a Bcr-Abl research tool. Its Src-family kinase activity creates a framework for connecting phosphorylation events with EMT, stemness, adhesion, invasion, and metastatic behavior—while the SNAI1–PIK3R2/p-EphA2 study shows why pathway and cell-state measurements must be interpreted together.

7966 records 4/532 page Previous Next 12345 下5页 Last page